iShares U.S. Healthcare ETF News - August 18, 2026

Bristol-Myers Squibb Wins FDA Approval for Iberdomide, Using Landmark Cancer Endpoint

The FDA approved Bristol-Myers Squibb’s iberdomide combination therapy for adults with relapsed or refractory multiple myeloma. This regimen combines...